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Introduction 
Concussion injury is defined as a complex pathophysiological process affecting the brain, 
induced by traumatic biomechanical forces1, and is the most common head injury 
experienced by American football players.2 However, head impacts commonly occur 
during American football games in which visible signs or symptoms of neurological 
dysfunction may not develop3-6, despite those impacts having the potential for neurological 
injury.7,8 Studies have shown that even a minor head injury with no concussive symptoms 
(subconcussion) can lead to abnormal results in neuropsychological tests, abnormal 
functional MRI (fMRI), and chronic traumatic encephalopathy (CTE).7-11 
This raises the question of whether or not ordinary American football play, without 
incidence of concussion, may cause immediate brain injury. Therefore, the purpose of the 
current study was to determine if serum concentrations of biochemical markers of brain 
injury are elevated following an American football game in athletes who sustained 
subconcussive head impacts not significant enough to cause clinical symptoms of brain 
injury. Numerous biomarkers of head injury have been discovered and their efficacy of 
detecting and predicting severity of traumatic brain injury have been tested in the clinical 
setting.12-14 However, few of these discovered biomarkers have been analyzed in their 
ability to detect sports-related head injury.15 Since S100B and NSE have been monitored 
quite frequently and appear to correlate well with number of head impacts they were chosen 
as the biomarkers for this study.16-19 Creatine kinase (CK) and Cortisol serum levels were 
also measured to estimate muscle damage and stress respectively. It was hypothesized that 
NSE, S100B, and CK would increase significantly as a result of the football game, while 
cortisol levels would not increase significantly. 
Materials and methods 
Subjects 
Seventeen (4 offensive lineman, 3 defensive linemen, 3 running backs, 3 linebackers, 2 
quarterbacks, 1 defensive back, and 1 punter) male Division III collegiate American 
football players who were members of the junior varsity team participated in this study. 
Players had a mean age of 19. 5 years (SD = 0.94), height of 1.83 m (SD = 0.07), and lean 
mass of 70.6 kg (SD = 10.0). Informed written consent was obtained from all subjects and 
the University of Wisconsin-Platteville Institutional Review Board for the protection of 
human subjects (Platteville, Wisconsin) approved the study (IRB Protocol #2015-16-15). 
Study design 
Prior to the first and only junior varsity football game of the season (eight weeks following 
the start of the varsity season) anthropometric data was collected from all subjects. Body 
weight and height were measured using a physician scale and height rod (DETECTO, 
Webb City, MO USA), while Dual-energy X-ray Absorptiometry (DXA) whole body scans 
were performed on all subjects using a Hologic Horizon Wi bone densitometer (Hologic, 
Inc., Marlborough, MA USA) to obtain lean mass measures. 
Two days prior and approximately one hour following the junior varsity football game, 
venous blood was collected from all subjects. Pregame blood was drawn and each subject 
acted as his own control. Blood was drawn from a prominent vein in the antecubital space 
using a 21-gauge butterfly needle with a 7 inch luer lock extension (Becton-Dickinson, 
Franklin Lakes, NJ USA) connected to a vacutainer adapter (Becton-Dickinson, Franklin 
Lakes, NJ USA). The blood was collected into a 4 ml serum separation vacutainer tube 
(Becton-Dickinson, Franklin Lakes, NJ USA). 
Biochemical analysis 
Following blood collection all samples were allowed to incubate at room temperature for 
one hour. Immediately after the one hour incubation period each sample was centrifuged at 
3500 RPM for 10 minutes at 4°C using a Thermo IEC Centra CL3 centrifuge (Thermo 
Fisher Scientific, Inc., Walthum, MA USA). Serum was then removed from each sample 
and placed in serum transfer tubes for subsequent analysis of NSE, S100B, and CK. 
Samples were then stored at 5°C for cortisol analysis which occurred within 72 hours of 
initial storage. 
Neuronal specific enolase. NSE was measured using a commercially available enzyme 
immunometric assay (EIA) kit (CanAg NSE EIA 420-85, Fujirebio Diagnostics, Inc., 
Göteborg, Sweden). This is a solid phase, non-competitive immune assay utilizing two 
monoclonal antibodies (MAb) derived from mice. The monoclonal antibodies are specific 
for the γ-subunit of NSE and therefore detect both the γγ and αγ isoenzymes of NSE. The 
serum samples and calibrators were first added to streptavidin coated microstrips and then 
were incubated with both a biotinylated anti-NSE MAb and an anti-NSE MAb labelled 
with horseradish peroxidase (HRP). Following this incubation period a hydrogen peroxide 
(H2O2) and 3, 3’, 5, 5’ tetramethyl-benzidine (TMB) substrate solution was added. The 
HRP-H2O2 oxidizes the TMB forming a blue color in which the absorbance of the color at 
620 nm is directly proportional to the concentration of NSE. All absorbance measurements 
were made using an Epoch microplate spectrophotometer (BioTek Instruments, Inc., 
Winooski, VT, USA). 
The known standards were then used to develop a calibration curve which was used to 
determine the NSE concentration in each serum sample. The sensitivity of the NSE assay 
ranged from 1-150 μg·L-1. Analysis of standards and samples were all performed in 
duplicate. The NSE assay performed before the football game gave a calibration curve with 
an R2 = 0.9977 and the intra-assay coefficient of variation (CV) was 4.3%. After the 
football game the NSE assay calibration curve was generated with an R2 = 0.9996 and the 
intra-assay CV was 9.4%. Inter-assay CV between the pregame and post-game NSE assays 
was 6.3%. 
Protein S-100B. Protein S-100B was measured using a commercially available EIA kit 
(CanAg S100 EIA 708-85, Fujirebio Diagnostics, Inc., Göteborg, Sweden). This EIA is a 
solid-phase, two-step non-competitive immunoassay utilizing two MAb from mice that are 
specific to the B monomer of protein S-100 such that the assay identifies both protein S-
100BB and protein S-100A1B. The assay requires that the serum samples and calibrators 
are incubated in streptavidin coated strips with a biotinylated Anti-S100B MAb. Following 
this incubation period an Anti-S100B MAb conjugated with HRP is added to the strips and 
allowed to incubate before adding an H2O2 buffered TMB substrate. HRP-H2O2 then 
metabolizes the TMB forming a blue color at which the intensity is directly proportional to 
serum S100B concentration. The absorbance of this blue color was measured at 620 nm 
using an Epoch microplate spectrophotometer (BioTek Instruments, Inc., Winooski, VT, 
USA). The known standards were then used to develop a calibration curve which was used 
to determine the S100B concentration in each serum sample. The sensitivity of the S100B 
assay ranged from 10-3500 ng·L-1. Analysis of standards and samples were all performed in 
duplicate. The S100B assay performed before the football game gave a calibration curve 
with an R2 = 0.9942 and the intra-assay CV was 3.6%. After the football game the S100B 
assay calibration curve was generated with an R2 = 0.9936 and the intra-assay CV was 4.9 
%. Inter-assay CV between the pregame and post-game S100B assays was 5.2%. 
Creatine kinase. Creatine Kinase was measured using a commercially available CK activity 
assay kit (Catalog No. MAK116; Sigma-Aldrich, St. Louis, MO, USA). CK is a dimeric 
protein made up of both muscle (M) and brain (B) subunits; however, this assay does not 
distinguish between types of CK. All serum samples and a calibrator were incubated with 
adenosine diphosphate (ADP), phosphocreatine (PC), hexokinase, glucose, glucose-6-
phosphate dehydrogenase, and nicotinamide adenine dinucleotide phosphate (NADP). The 
CK present in each sample converts ADP and PC to ATP and creatine. The ATP is then 
used by hexokinase to phosphorylate glucose to glucose-6-phosphate. Glucose-6-phosphate 
is then oxidized by glucose-6-phosphate dehydrogenase forming NADPH and 6-phospho-
D-gluconate. The production of NADPH was measured at 340 nm using an Epoch 
microplate spectrophotometer (BioTek Instruments, Inc., Winooski, VT, USA). The 
increase of absorbance at 340 nm is directly proportional to the activity of CK. One unit of 
CK is the amount of enzyme that will transfer 1μmole of phosphate from PC to ADP per 
minute at a pH of 6.0. This assay was carried out over a period of 20 minutes where the 
absorbance was read immediately after plate preparation (initial) and then after a 20 minute 
incubation period (final). The following formula was used to calculate CK activity in 
Units·L-1. 
 
CK = (A340)final – (A340)initial      x 150 
                     (A340)calibrator – (A340)blank 
 
Where (A340)final = the final absorbance of NADPH at 340 nm, (A340)initial = the initial 
absorbance of NADPH at 340 nm, (A340)calibrator = the absorbance of the calibrator at 340 
nm, (A340)blank = the absorbance of the blank (deionized water) at 340 nm, and 150 = the 
equivalent activity (Units·L-1) of the calibrator when the assay is read at 20 minutes and 40 
minutes. The sensitivity of the CK assay ranged from 30-1800 U·L-1. The intra-assay CV 
was 3.8% before the football game. After the football game the intra-assay CV was 1.6%. 
Inter-assay CV between the pregame and post-game S100B assays was 3.6%. 
Cortisol. Cortisol was measured using a commercially available enzyme-linked 
immunsorbent (ELISA) assay kit (Catalog No. SE120037; Sigma-Aldrich, St. Louis, MO, 
USA). This ELISA is a solid-phase, competitive immunoassay utilizing two anti-cortisol 
MAb. Serum samples and standards were incubated in anti-cortisol MAb coated wells with 
anti-cortisol MAb enzyme conjugate. TMB substrate was then added to the wells and the 
intensity of color is inversely proportional to cortisol concentration. The intensity of color 
was measured at an absorbance of 450 nm using an Epoch microplate spectrophotometer 
(BioTek Instruments, Inc., Winooski, VT, USA). Analysis of standards and samples were 
all performed in duplicate. The sensitivity of the cortisol assay ranged from 0-800 ng·ml-1. 
The intra-assay CV was 4.7%. Since the cortisol assay for both pre- and postgame samples 
were performed on the same plate at the same time there was no inter-assay CV. The 
cortisol standard curve is not linear; therefore, neither an R2 value nor a predictive equation 
could be generated. Because of this, the cortisol concentrations were estimated visually 
based off the standard curve. 
Statistical analysis 
All statistical analyses were generated using SPSS version 22 (SPSS Inc., Chicago, IL 
USA). Means of NSE, S100B, CK, and cortisol serum concentration pregame were 
compared to post-game using two-tailed paired-samples t-tests for parametric data. 
Normality was analyzed using a Shapiro-Wilk test with an alpha level of 0.05, while 
homogeneity of variance was analyzed using Levene’s test with an alpha level of 0.05. A 
Wilcoxon rank-sum test was used for data not meeting the assumption for normality, and a 
Welch t-test was used for data not meeting the assumption for homogeneity of variance. A 
95% confidence interval (CI) was used to assign bounds of expected discrepancy between 
the sample mean and the population mean. A Cohen’s d (d) test using the original standard 
deviations (as opposed to the pooled standard deviations)20 was performed to determine the 
effect size that the football game had on each variable. A two-tailed Pearson Correlation 
Coefficient was used to measure the relationship between S100B and body mass, along 
with S100B and CK. Data is reported as mean (SD) and alpha was set at 0.05 to determine 
statistical differences between means. 
Results 
Mean serum NSE concentration was significantly different between pregame and postgame 
(p < 0.001; d = 1.2; observed power = 0.915). Pregame serum NSE concentration was an 
average of 7.0 μg·L-1 (SD = 2.2; 95% CI: 5.8 – 8.1 μg·L-1) while mean serum NSE 
postgame was 13.1 μg·L-1 (SD = 7.0; 95% CI: 9.5 – 16.7 μg·L-1). Figure 1 shows mean ± 
SD NSE pregame and postgame data. The average serum concentration of S100B was also 
significantly greater postgame as compared to pregame (p < 0.001; d = 2.1; observed power 
= 1.000). Pregame serum S100B concentration was an average of 0.013 μg·L-1 (SD = 
0.012; 95% CI: 0.007 – 0.019 μg·L-1) while mean serum S100B postgame concentration 
was 0.069 μg·L-1 (SD = 0.036; 95% CI: 0.050 – 0.087 μg·L-1). Figure 2 shows mean ± SD 
S100B pregame and postgame data. 
Neither serum CK (p = 0.116; d = 0.56; observed power = 0.349) nor serum cortisol 
concentration (p = 0.876; d = 0.12; observed power = 0.059) changed significantly from 
pregame to post game. Pregame serum CK concentration was an average of 90.5 U·ml-1 
(SD = 41.9; 95% CI: 70.0 – 112.1 U·ml-1) while mean serum CK postgame concentration 
was 120.2 U·ml-1 (SD = 62.7; 95% CI: 87.9 – 152.4 U·ml-1). Figure 3 shows mean ± SD 
CK pregame and postgame. Pregame serum cortisol concentration was an average of 369.2 
nmoles·L-1 (nM) (SD = 159.8; 95% CI: 287.0 – 451.4 nM) while mean serum cortisol 
postgame concentration was 353.0 nM (SD = 170.5; 95% CI: 265.3 – 440.6 nM) Figure 4 
shows mean ± SD cortisol pregame and postgame data. Figure 5 shows that little 
correlation was found between postgame S100B serum concentration and body mass (R2 = 
0.029, p = 0.911); and low correlation was found between postgame S100B serum 
concentration and postgame CK serum concentration (R2 = 0.353, p = 0.165). 
[Insert figures 1-5]. 
Discussion 
This research was conducted as a pilot study to determine if head injury occurs during one 
American football game due to subconcussive impacts without the occurrence of 
concussion or mild traumatic brain injury symptoms. During the football game no 
concussions or traumatic head injuries were reported by the players or observed by the 
athletic training staff. Despite no clinical evidence of brain injury both serum NSE and 
S100B increased significantly following the football game. The increase in serum levels of 
NSE and S100B following the football game coincide with previous studies analyzing these 
two biomarkers before and after athletic competition.16,17,21-26 Surprisingly, CK levels did 
not rise significantly following the football game as has been reported in past studies 
following athletic competition.16,17,26,27 Cortisol has been shown to increase following head 
injury28, including boxing bouts with punches to the head16 but has not been reported to 
increase significantly following an American football game27 when head injury is not 
present. The findings of cortisol not increasing following a sporting event in which no head 
injuries have occurred agrees with the results of our study. 
The postgame serum concentration of 13.1 μg·L-1 for NSE is around the normal serum 
range of 12.5 μg·L-1 for healthy humans14 and similar to those levels found following a 
game or match in other contact sports.23–25 As expected, the concentration of 13.1 μg·L-1 
following the football game was lower than that found in individuals following a boxing 
match (31.1 μg·L-1)16 or karate event (20.2 μg·L-1)17 in which punches and kicks to the 
head were prevalent. Interestingly, the median NSE concentration of 11.2 μg·L-1 found after 
the football game in our study was greater than the median concentration of 6.5 μg·L-1 
found after concussion injury in ice hockey players.22 This low level of NSE concentration 
in the serum of concussed ice hockey players has brought the usefulness of NSE as a 
marker of sports related head injury into question.22 
The presence of NSE in thrombocytes and erythrocytes14 also brings the usefulness of 
measuring NSE to assess head injury into question. There is concern of erythrocyte lysis 
during competition29 and analysis30 which may cause a false interpretation of elevated NSE. 
Indeed, a limitation to our study is that we did not measure hemolysis of blood samples. 
However, due to immediate processing and analyzing of the serum samples, and the normal 
serum concentrations of NSE observed in the pregame samples, it is unlikely that 
significant hemolysis due to our handling of the blood specimens occurred.30 In addition, 
Skogseid et al. (1992) has reported that serum NSE levels in patients with multiple 
extracerebral injury have still been shown to correlate only with brain injury31, implying 
that the brain is the main source of NSE. Further research into the usefulness of NSE as a 
biomarker of head injury caused by sports is warranted. 
Postgame, the mean S100B serum concentration of 0.069 μg·L-1 was within the normal 
serum concentration of 0.2 μg·L-1 found in healthy humans.14 This level was also lower 
than the values found post competition in swimmers32, runners18,33, soccer players24,25, ice 
hockey players23, basketball players23, boxers16,18, karate practitioners17, and concussed ice 
hockey players22. However, the postgame serum concentration was greater than found in 
subjects following cycling exercise.18 The change of serum S100B levels from pre to post 
game (0.056 μg·L-1) was similar to that found in other non-concussed football players.21,34 
As with NSE, the usefulness of S100B as a biomarker for head injury in sports has been 
called into question22,32,33 due to extra cranial sources of S100B in adipocytes, melanocytes, 
chondrocytes, and skeletal muscle tissue.35 
Support for the idea that S100B is a marker of muscle damage and not glial damage comes 
from studies that have found similar increases in both CK and S100B following running 
exercise26,33 along with increases in S100B after swimming.32 There is also evidence that 
subjects with greater body mass have greater levels of serum S100B.36 However, other 
studies have reported no increases in serum S100B in the absence of impacts to the brain18, 
26,37,38, and Pham et al. (2010) have reported that extracranial sources of S100B do not 
affect serum levels.39 Our results support the idea of serum S100B not being affected by 
extracranial sources as S100B was not correlated with CK or body mass. 
In Conclusion, the effect of the football game on levels of NSE (d = 1.2) and S100B (d = 
2.1) were large. However, the low NSE and S100B levels in the serum of subjects 
following this football game likely indicate two different possibilities: 1. That American 
football may be no more dangerous than other sports that cause axial vibrations or direct 
impacts to the head or 2. NSE and S100B may not be the ideal biomarkers for assessing 
head injury. 
Several limitations must be taken into consideration with this study. First of all, since this 
was a pilot study, there was a small number of subjects and lack of a separate control group 
doing no exercise, a group performing non-contact exercise, and a group that did not 
receive any playing time during the game. Furthermore, this data was collected from one 
game within a cohort of athletes who have not played any other games during the season. 
This was a junior varsity game in which many substitutions occurred to give the majority of 
players a chance to compete and prove their talent to the coach. In contrast, starting 
offensive and defensive varsity players participate in approximately 13 games per year and 
typically remain in the game for the full duration of offensive or defensive play, which may 
result in greater NSE, S100B, and CK serum concentrations in subjects following varsity 
games. Additional research must also be conducted in varsity athletes and national football 
league (NFL) players to determine if the findings of this study are similar when elite 
athletes with a greater body mass play the game of American football for a longer time 
period. 
There may also be biomarker differences by position which can be alluded to in our results 
but must be studied with a greater number of subjects per position for statistical inference. 
The use of equipment to gain biomechanical data such as: number of head and body 
impacts, magnitude of impacts, and location of impacts would also be of valuable 
assessment in conjunction with biomarker data. Lastly, although the results of this study 
indicate that American football does not inherently cause immediate brain injury, there is 
likely occurrence of brain injury with reported concussions, which may be detrimental to 
participation. Although the data presented here is interesting and unique, future studies 
should consider the use of larger subject numbers and a control group. 
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